Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
1.300
-0.070 (-5.11%)
At close: Feb 21, 2025, 4:00 PM
1.379
+0.079 (6.10%)
After-hours: Feb 21, 2025, 7:58 PM EST
Psyence Biomedical Ratios and Metrics
Market cap in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| Current | FY 2024 | FY 2023 | FY 2022 |
| Feb '25 Feb 21, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| Market Capitalization | 6 | 15 | 97 | 327 |
| Market Cap Growth | -97.86% | -84.31% | -70.25% | - |
| Enterprise Value | 5 | 15 | 96 | - |
| Last Close Price | 1.30 | 85.50 | 795.32 | 750.75 |
| PB Ratio | -4.59 | -1.39 | -485.52 | 154.09 |
| P/TBV Ratio | - | - | - | 154.09 |
| Debt / Equity Ratio | -1.04 | -0.95 | - | - |
| Quick Ratio | 0.59 | 0.06 | 0.83 | 13.62 |
| Current Ratio | 0.64 | 0.09 | 0.89 | 13.90 |
| Return on Equity (ROE) | - | - | -468.63% | - |
| Return on Assets (ROA) | -137.78% | -126.35% | -123.25% | - |
| Return on Capital (ROIC) | - | - | -295.49% | - |
| Earnings Yield | -809.55% | -335.13% | -3.29% | -0.71% |
| FCF Yield | -50.13% | -19.33% | -1.64% | -0.53% |
| Buyback Yield / Dilution | -239.30% | -30.34% | - | - |
| Total Shareholder Return | -239.30% | -30.34% | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.